Drug
Who makes mycophenolate mofetil hydrochloride?
2 companies list mycophenolate mofetil hydrochloride as a human prescription drug, including under the names CellCept. Forms: injection, powder, lyophilized, for solution. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing mycophenolate mofetil hydrochloride
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Genentech, Inc.United States | injection, powder, lyophilized, for solution | NDANDA050758 | 1 | 8 |
| BPI Labs, DBA Ally LabsUnited States | injection, powder, lyophilized, for solution | ANDAANDA214283 | 1 | 2 |
Enquiry
Common questions
- Who makes mycophenolate mofetil hydrochloride?
- 2 companies list mycophenolate mofetil hydrochloride as a human prescription drug in the openFDA NDC Directory, led by Genentech, Inc., BPI Labs, DBA Ally Labs. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic CellCept?
- 1 company lists mycophenolate mofetil hydrochloride under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.